SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo-Reference-Cited by-同舟云学术

SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo

Published:2010-11-21 Issue:1 Volume:14 Page:1-16
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Chao Wan-Ru,Amin Khalid,Shi Yihui,Hobbs Peter,Tanabe Mas,Tanga Mary,Jong Ling,Collins Nathan,Peters Richard,Laderoute Keith,Dinh Dominic,Yean Dawn,Hou Carol,Sato Barbara,Alt Carsten,Sambucetti Lidia

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-010-9191-z.pdf

Reference85 articles.

1. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31

2. Folkman J, Shing Y (1992) Angiogenesis. J Bio Chem 267:10931–10934

3. Folkman J, Kalluri R (2004) Cancer without disease. Nature 427:787

4. Yancopoulos GD, Davis S, Gale NW et al (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248

5. Rosen LS (2005) VEGF-targeted therapy: therapeutic potential and recent advances. Oncologist 10:382–391

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015);Expert Opinion on Therapeutic Patents;2016-02-16

2. Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration;Bioscience Reports;2015-11-26

3. Estrogen-related receptor alpha and cancer: axis of evil;Journal of Receptors and Signal Transduction;2015-10-08

4. Estrogen-Related Receptors in Breast Cancer and Prostate Cancer;Frontiers in Endocrinology;2015-05-26

5. Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer;Cancer Management and Research;2014-05